-
Januvia, Onglyza, And Certain Other Diabetes Drugs Linked To Inflammatory Bowel Disease (IBD)
New Study Finds Overall 75% Increase In Risk Of IBD, And Association Peaked Between 3 And 4 Years Of Use (Posted by Tom Lamb at DrugInjuryWatch.com) According to an observational study published…
-
Uloric Drug Safety Update: A Significantly Higher Risk Of Death Among Patients Using Gout Drug Uloric As Opposed To Allopurinol
Recent Findings Come From The CARES Trial, A Postmarketing Safety Study Requested By FDA Back When Uloric Was Approved In 2009 (Posted by Tom Lamb at DrugInjuryWatch.com) At the recent American College…
-
Tasigna Side Effects Include Ischemic Cerebrovascular Events, Ischemic Heart Disease, And Peripheral Arterial Occlusive Disease
Less Warning About These Atherosclerosis-Related Diseases By Novartis In The US, It Seems, Compared To What Has Been Done By The Drug Company In Canada (Posted by Tom Lamb at DrugInjuryWatch.com) Tasigna…
-
Four Distinct Diabetes Drugs MDL Cases: Byetta / Januvia / Victoza; Onglyza / Kombiglyze; Invokana; Farxiga
Current Number Of Drug Injury Lawsuits Filed In Each Of These Ongoing Federal Court MDL Cases: February 2018 JPML Report (Posted by Tom Lamb at DrugInjuryWatch.com) At the present time there are…
-
Kombiglyze And Onglyza MDL For Federal Court Lawsuits Filed Against Responsible Drug Companies
This Diabetes Drugs Litigation Involves Heart Failure, Myocardial Infarction, And Other Cardiovascular Problems (Posted by Tom Lamb at DrugInjuryWatch.com) In February 2018 the United States Judicial Panel on Multidistrict Litigation (JPML) established…
